Qingdao Kowloon biotechnology co., LTD. Is a collection of scientific research, production, sales in the integration of biological pharmaceutical enterprises, the company has production and heparin sodium chondroitin sulfate two drugs, chondroitin sulfate and heparin API is China the production of the larger manufacturers, and the two projects are also passed the state food and drug administration GMP certification, The products are well received by the United States, Germany, Britain, The Netherlands, Spain, Italy, Switzerland, India, Japan, South Korea, Russia, Egypt and other countries and regions.
The heparin sodium products produced by Jiulong Biomedicine are pure biological agents extracted from the small intestine of pigs. The enterprise mainly produces bulk drugs. At present, the international demand for heparin sodium is mostly macromolecular heparin sodium, which has low profit margin and slow product iteration once reduced the enterprise's profit. To this end, enterprises continue to strengthen the investment in research and development, the development of low molecular weight heparin sodium, with technical strength to seize the international and domestic market.